Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hruby

Showing results (721-730 of 762) with videos related to

Pageof 77
Sort By:
Journal of Medicinal Chemistry|July 13, 2010
Biological and conformational evaluation of bifunctional compounds for opioid receptor agonists and neurokinin 1 receptor antagonists possessing two penicillaminesTakashi Yamamoto, Padma Nair, Neil E Jacobsen, et al.
Bioorganic & Medicinal Chemistry Letters|September 2, 2015
Design and synthesis of novel bivalent ligands (MOR and DOR) by conjugation of enkephalin analogues with 4-anilidopiperidine derivativesSrinivas Deekonda, Lauren Wugalter, David Rankin, et al.
Cardiovascular Research|November 8, 2012
α-Melanocyte-stimulating hormone regulates vascular NO availability and protects against endothelial dysfunctionPetteri Rinne, Wendy Nordlund, Ilkka Heinonen, et al.
Journal of Medicinal Chemistry|March 4, 2011
Discovery of a potent and efficacious peptide derivative for δ/μ opioid agonist/neurokinin 1 antagonist activity with a 2',6'-dimethyl-L-tyrosine: in vitro, in vivo, and NMR-based structural studiesTakashi Yamamoto, Padma Nair, Tally M Largent-Milnes, et al.
Brain : a Journal of Neurology|December 4, 2008
Neuropathic pain is maintained by brainstem neurons co-expressing opioid and cholecystokinin receptorsWenjun Zhang, Shannon Gardell, Dongqin Zhang, et al.
Journal of Neurochemistry|November 23, 2017
Protection against β-amyloid neurotoxicity by a non-toxic endogenous N-terminal β-amyloid fragment and its active hexapeptide core sequenceKelly H Forest, Naghum Alfulaij, Komal Arora, et al.
Journal of Medicinal Chemistry|September 30, 2008
The importance of micelle-bound states for the bioactivities of bifunctional peptide derivatives for delta/mu opioid receptor agonists and neurokinin 1 receptor antagonistsTakashi Yamamoto, Padma Nair, Neil E Jacobsen, et al.
Journal of Medicinal Chemistry|March 8, 2012
The cis-4-amino-L-proline residue as a scaffold for the synthesis of cyclic and linear endomorphin-2 analoguesAdriano Mollica, Francesco Pinnen, Azzurra Stefanucci, et al.
Molecular Psychiatry|May 10, 2017
Genetic and pharmacological antagonism of NK<sub>1</sub> receptor prevents opiate abuse potentialA J Sandweiss, M I McIntosh, A Moutal, et al.
Journal of Medicinal Chemistry|November 1, 1987
alpha-Melanotropin: the minimal active sequence in the frog skin bioassayV J Hruby, B C Wilkes, M E Hadley, et al.
Pageof 77

Showing results (721-730 of 762) with videos related to

Sort By:
Pageof 77
Journal of Medicinal Chemistry|July 13, 2010
Biological and conformational evaluation of bifunctional compounds for opioid receptor agonists and neurokinin 1 receptor antagonists possessing two penicillaminesTakashi Yamamoto, Padma Nair, Neil E Jacobsen, et al.
Bioorganic & Medicinal Chemistry Letters|September 2, 2015
Design and synthesis of novel bivalent ligands (MOR and DOR) by conjugation of enkephalin analogues with 4-anilidopiperidine derivativesSrinivas Deekonda, Lauren Wugalter, David Rankin, et al.
Cardiovascular Research|November 8, 2012
α-Melanocyte-stimulating hormone regulates vascular NO availability and protects against endothelial dysfunctionPetteri Rinne, Wendy Nordlund, Ilkka Heinonen, et al.
Journal of Medicinal Chemistry|March 4, 2011
Discovery of a potent and efficacious peptide derivative for δ/μ opioid agonist/neurokinin 1 antagonist activity with a 2',6'-dimethyl-L-tyrosine: in vitro, in vivo, and NMR-based structural studiesTakashi Yamamoto, Padma Nair, Tally M Largent-Milnes, et al.
Brain : a Journal of Neurology|December 4, 2008
Neuropathic pain is maintained by brainstem neurons co-expressing opioid and cholecystokinin receptorsWenjun Zhang, Shannon Gardell, Dongqin Zhang, et al.
Journal of Neurochemistry|November 23, 2017
Protection against β-amyloid neurotoxicity by a non-toxic endogenous N-terminal β-amyloid fragment and its active hexapeptide core sequenceKelly H Forest, Naghum Alfulaij, Komal Arora, et al.
Journal of Medicinal Chemistry|September 30, 2008
The importance of micelle-bound states for the bioactivities of bifunctional peptide derivatives for delta/mu opioid receptor agonists and neurokinin 1 receptor antagonistsTakashi Yamamoto, Padma Nair, Neil E Jacobsen, et al.
Journal of Medicinal Chemistry|March 8, 2012
The cis-4-amino-L-proline residue as a scaffold for the synthesis of cyclic and linear endomorphin-2 analoguesAdriano Mollica, Francesco Pinnen, Azzurra Stefanucci, et al.
Molecular Psychiatry|May 10, 2017
Genetic and pharmacological antagonism of NK<sub>1</sub> receptor prevents opiate abuse potentialA J Sandweiss, M I McIntosh, A Moutal, et al.
Journal of Medicinal Chemistry|November 1, 1987
alpha-Melanotropin: the minimal active sequence in the frog skin bioassayV J Hruby, B C Wilkes, M E Hadley, et al.
Pageof 77